newsfilter
← Latest News
GlobeNewswire·

NANOBIOTIX to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

  • Nanobiotix (NASDAQ: NBTX) announced its management will participate in a fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference.
  • The event is scheduled for Tuesday, September 15, 2026, at 12:00 pm EDT (6:00 pm CEST) in New York, NY.
  • Company representatives presenting include Laurent Lévy, Chief Executive Officer, & Bart Van Rhijn, Chief Financial & Business Officer.
  • Nanobiotix is a late-stage clinical biotechnology company headquartered in Paris, France, with a subsidiary in Cambridge, Massachusetts.
  • The company is listed on Euronext Paris since 2012 & on the Nasdaq Global Select Market since December 2020.
  • Nanobiotix holds over 30 umbrella patents covering three nanotechnology platforms for oncology, bioavailability & biodistribution, & central nervous system disorders.
  • The press release includes forward-looking statements regarding financial resources & cash runway projections, accompanied by standard risk factor disclaimers referencing SEC Form 20-F & AMF filings.